Send to:

Choose Destination
See comment in PubMed Commons below
J Health Commun. 2004 Nov-Dec;9(6):529-40.

Is the information "fair and balanced" in direct-to-consumer prescription drug websites?

Author information

  • 1School of Journalism and Mass Communication, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA.


This study applies the Food and Drug Administration's (FDA's) "fair-balance disclosure" provision to examine the content of prescription drug websites, specifically focusing on the quantity and quality of risk information. The results show that even though most prescription drug websites provide both risk and benefit information, the two types of information are presented differently. This study suggests directions for regulators to consider in writing a more specific rule to ensure that information on prescription drug websites is balanced.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk